Other Clinical Trial - Waterjet Versus Ultrasound Dissection During

Clinical Trial Description

Transection time, bloodloss, total operation time and postoperative complication rates are registered. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Liver Tumour

See also
Status	Clinical Trial	Phase
Terminated	`NCT01726465` - Methylprednisolone N Acetylcysteine in Hepatic Resections	Phase 2
Completed	`NCT02181075` - Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours	Phase 1
Completed	`NCT01082419` - Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity	N/A

See also

Status

Clinical Trial

Phase

Terminated

NCT01726465 - Methylprednisolone N Acetylcysteine in Hepatic Resections

Phase 2

Completed

NCT02181075 - Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours

Phase 1

Completed

NCT01082419 - Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02041065
Study type	Interventional
Source	Karolinska University Hospital
Contact
Status	Completed
Phase	Phase 2
Start date	February 2011
Completion date	March 2015

Waterjet Versus Ultrasound Dissection During Hepatic Transection

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms